REDHILL BIOPHARMA LTD. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
REDHILL BIOPHARMA LTD. (RDHL) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$1.76 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2022-06-30 was -$1.83M.
- REDHILL BIOPHARMA LTD. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2021-06-30 was -$24.17M.
- REDHILL BIOPHARMA LTD. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2020-06-30 was -$59.37M.
- REDHILL BIOPHARMA LTD. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2019-06-30 was -$14.04M.
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 3 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|---|
| 2025-06-30 | -$1.76M 6-K · filed 2025-09-05 | ||
| 2024-12-31 | -$961.00K 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $1.71M 6-K · filed 2025-09-05 | ||
| 2023-12-31 | -$14.38M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | -$12.97M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | -$9.43M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | -$1.83M 6-K · filed 2022-11-07 | -$2.44M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $275.00K 20-F · filed 2024-04-08 | ||
| 2021-06-30 | -$24.17M 6-K · filed 2022-11-07 | $22.61M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $142.00K 20-F · filed 2023-04-28 | ||
| 2020-06-30 | -$59.37M 6-K · filed 2021-08-26 | -$6.91M 6-K · filed 2021-08-26 | |
| 2019-12-31 | -$76.00K 20-F · filed 2022-03-17 | ||
| 2019-06-30 | -$14.04M 6-K · filed 2020-08-13 | -$20.05M 6-K · filed 2020-08-13 | |
| 2018-12-31 | $12.65M 20-F · filed 2021-03-18 | ||
| 2018-06-30 | -$1.94M 6-K · filed 2019-07-23 | -$10.82M 6-K · filed 2019-07-23 | |
| 2017-12-31 | -$37.70M 20-F · filed 2020-03-04 | ||
| 2017-06-30 | -$14.42M 6-K · filed 2018-08-30 | -$38.83M 6-K · filed 2018-08-30 | |
| 2016-12-31 | $32.23M 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $15.77M 20-F · filed 2018-02-22 |